OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2025-03-31-accounts

Charity Registra�on No. 1023606

Company Registra�on No. 2806607 (England and Wales)

NEUROMUSCULAR CENTRE

COMPANY LIMITED BY GUARANTEE

ANNUAL REPORT AND FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2025

NEUROMUSCULAR CENTRE COMPANY LIMITED BY GUARANTEE LEGAL AND ADMINISTRATIVE INFORMATION

Trustees M Hawes D Okell (Chair to 2 May 2024) M Roberts (not a director) W Stothart S Monteiro W Duckworth (Chair from 2 May 2024) R Diaz J Haskey R Woodward (Appointed 17 July 2025) S Vaja (Appointed 17 July 2025) G Hinds (Appointed 17 July 2025) Chief Execu�ve B Edson Secretary B Dale Charity number 1023606 Company number 2806607 Registered office Woodford Lane West Winsford Cheshire CW7 4EH Auditors Mitchell Charlesworth (Audit) Limited Suites C,D,E, & F 14th Floor The Plaza 100 Old Hall Street Liverpool L3 9QJ Bankers Barclays Bank Plc 21 Dingle Walk Winsford Cheshire CW7 1AG Na<onwide Building Society 5­11 St George Street Douglas Isle of Man IM99 1AS Solicitors Barrow & Cook 5­7 Victoria Square St Helens Merseyside WA10 1HH

NEUROMUSCULAR CENTRE COMPANY LIMITED BY GUARANTEE CONTENTS

Page
Trustees' report 1 ­ 6
Statement of trustees' responsibili�es 7
Independent auditor's report 8 ­ 10
Statement of fnancial ac�vi�es 11 ­ 12
Balance sheet 13
Statement of cash fows 14
Notes to the fnancial statements 15 ­ 33

NEUROMUSCULAR CENTRE COMPANY LIMITED BY GUARANTEE TRUSTEES' REPORT (INCLUDING DIRECTORS' REPORT)

FOR THE YEAR ENDED 31 MARCH 2025

The trustees present their annual report and financial statements for the year ended 31 March 2025.

The financial statements have been prepared in accordance with the accoun�ng policies set out in note 1 to the financial statements and comply with the charity's memorandum and ar�cles of associa�on (as amended 17 October 2019), the Companies Act 2006 and "Accoun�ng and Repor�ng by Chari�es: Statement of Recommended Prac�ce applicable to chari�es preparing their accounts in accordance with the Financial Repor�ng Standard applicable in the UK and Republic of Ireland (FRS 102) (effec�ve 1 January 2019)".

Objec�ves and ac�vi�es

The NMC is the Centre of Excellence for people affected by neuromuscular condi�ons.

Charitable objects

The objects of the NMC are to promote and provide opportuni�es for people with a neuromuscular condi�on to live fuller lives through training, employment and physiotherapy, together with advice and support for themselves and their families and carers.

Mission

The NMC's mission is to work together with people affected by muscle diseases, crea�ng an environment where full poten�al and posi�ve wellbeing are achieved, through employment, training, support and physiotherapy.

Aims and ac�vi�es

The NMC aims to be largely user led and to provide a range of services for people affected by muscle disease. Although service users are predominantly from within a 100 mile radius of Winsford, Cheshire, many a<end the Centre from across the UK and Europe. The range of services includes:

The unique combina�on of services provided by the charity are offered directly to individuals and their families across the UK. Where prac�cable, physical management programmes are tailored to the needs of each individual, depending on their type of dystrophy and physical condi�on, through regular sessions of physiotherapy and hydrotherapy. As a ‘centre of excellence’ in the physical management of muscular dystrophy and related neuromuscular condi�ons, the charity offers help and advice to other organisa�ons worldwide.

The charity has established a well­respected graphic design business, NMC Design+Print, in which the variety of skills and talents of the individuals can be employed, developed and rewarded under both salaried and permi<ed work arrangements. The NMC provides wheelchair­adapted transport for individuals a<ending the Centre.

NEUROMUSCULAR CENTRE COMPANY LIMITED BY GUARANTEE TRUSTEES' REPORT (CONTINUED)(INCLUDING DIRECTORS' REPORT)

FOR THE YEAR ENDED 31 MARCH 2025

NMC strategy for 2025­27

In early 2024 we endorsed our 6 strategic objec�ves for NMC. These were first developed in 2022 and have now been reviewed. They remain our primary goals;

Objec�ve 1

Provide impac(ul social and academic opportuni�es for our community

Objec�ve 2

Enrich the emo�onal and physical wellbeing of people affected by neuromuscular condi�ons

Objec�ve 3

Inspire, inform, and enable our community to make an ac�ve contribu�on to society

Objec�ve 4

Develop a thorough understanding of people in our community and respond in tailored ways

Objec�ve 5

Run an effec�ve and professional organisa�on with excellent governance with sustainability at the core

Objec�ve 6

Volunteer help

NMC has a strong group of volunteers working in:

The charity trustees consider that they have complied with their duty in sec�on 17 of the Chari�es Act 2011 to have due regard to public benefit guidance published by the Charity Commission and that the benefits that the charity provides are not unreasonably restricted.

Achievements against our carried forward goals from 2023­24

  1. Explore the provision of accessible accommoda�on near to the NMC. This is now not a goal due to changing demand post Covid.

  2. Con�nue to develop and exploit the opportuni�es provided to NMC Design+Print following the investment in the Laser cu<er/engraver . It became apparent that a commercial laser cu�ng/engraving service was not viable so this ac�vity has amalgamated with the crea�ve ac�vi�es on offer.

  3. Improve outdoor accessibility onsite. This includes relaying the car park and re­furbishing and extending accessible paths and boardwalks. Car park refurbishment complete. Path improvements s�ll to complete. Path improvements planned for early 2025­26.

  4. Develop a new Fundraising Strategy to reflect changes in society, the marketplace for events, our changed capacity, and the end of our long running Spirit of Christmas fundraising event. Lots of scoping has been undertaken. A new strategy is emerging but not yet completed. Comple�on of the Strategy is a goal for 2025­26.

  5. 2 -

NEUROMUSCULAR CENTRE COMPANY LIMITED BY GUARANTEE TRUSTEES' REPORT (CONTINUED)(INCLUDING DIRECTORS' REPORT)

FOR THE YEAR ENDED 31 MARCH 2025

Achievements against our goals for 2024­25

  1. Upgrade and extend the outside paths to enable people to explore the meadow and gardens in all seasons safely. Not achieved but planned for early 2025­26

  2. Develop the new Employment and Careers service so it achieves all that we have planned for it in terms of placing people in work/work experience, preparing for work, and helping people stay in work by adapng to changes in condion. Achieved

  3. Prepare NMC for a Britain in Bloom applicaon and maximise involvement of our community as well as local volunteers in developing a flourishing and a0racve garden. Achieved

  4. Develop a new fundraising strategy to reflect changing *mes and the end of our long running Spirit of Christmas event. Not achieved but planned for 2025­26

  5. Develop an accommodaon offer for those travelling long distances to NMC. The accommodaon could also offer accessible holiday op*ons and a place to try out independent living. This is now not a goal due to changing demand post Covid.

  6. The arrival, inducon and successful handover to the new Chief Execuve will be an important element of the plans for the charity in the year ahead. Achieved

  7. We plan to upgrade and modernise our heang system and install addional solar power generaon to reduce our energy consumpon and increase the sustainability of our provision. Par*ally achieved. Funding for improvements received in 2024­25, to be spent in 2025­26

Fundraising performance

Donors to NMC can be assured that we comply with the regulatory standards for fundraising. The charity adheres to the Code of Fundraising Pracce in all its fundraising acvies. Through this guidance, policies and working pracces relang to working with vulnerable supporters, handling complaints and ethical consideraons are in place.

NMC does not sub­contract elements of its fundraising acvies to marke*ng agencies and undertakes all its correspondence and contact with donors in­house.

The charity received no fundraising complaints during the year. Complaints are dealt with in line with our complaints policy, with most serious complaints escalated to our Trustees so they can consider lessons to be learnt.

NMC has safeguarding policies in place to protect vulnerable people. Our fundraisers (both staff and third party) are familiarised with these to ensure the correct procedures are in place.

Financial review

Prior year adjustment

The prior year figures have been adjusted which has decreased the 2024 surplus, which is now £36,018, more detail is shown in note 31.

NEUROMUSCULAR CENTRE COMPANY LIMITED BY GUARANTEE TRUSTEES' REPORT (CONTINUED)(INCLUDING DIRECTORS' REPORT)

FOR THE YEAR ENDED 31 MARCH 2025

Reserves policy

NMC recognises the need to hold adequate reserves, to ensure that the charity has a reasonable and propor�onate "buffer" against the risk of unforeseen problems, whilst also recognising the pursuit of our charitable objec�ves means we should not hold excessive reserves.

NMC reserves policy is to target unrestricted free reserves to remain between 3 and 6 months of average expenditure. This policy should be reviewed by Trustees every year

The current reserves level is £1,413,987 with restricted reserves being £7,343, endowment fund reserves of £75,000 and unrestricted funds represented by fixed assets of £743,805 leaving free reserves of £587,839.

Risk management

A register of risks is maintained and reviewed regularly by the Trustees.

The following risks have been iden�fied as the most significant for the charity:

Plans for 2025­26

NEUROMUSCULAR CENTRE COMPANY LIMITED BY GUARANTEE TRUSTEES' REPORT (CONTINUED)(INCLUDING DIRECTORS' REPORT)

FOR THE YEAR ENDED 31 MARCH 2025

Structure, governance and management

The Neuromuscular Centre (NMC) is a registered charity, incorporated as a company limited by guarantee. The charity registra�on number is 1023606 and the company registra�on number is 2806607. The NMC has a wholly owned dormant subsidiary, NMC Trading Limited.

The trustees, who are also the directors for the purpose of company law, and who served during the year were:

M Hawes I Mar�n (Resigned 1 October 2024) D Okell (Chair to 2 May 2024) M Roberts (not a director) W Stothart S Monteiro W Duckworth (Chair from 2 May 2024) R Diaz J Haskey R Woodward (Appointed 17 July 2025) S Vaja (Appointed 17 July 2025) G Hinds (Appointed 17 July 2025)

Appointment of trustees

The charity appointed its Board of Trustees from 1 April 2012. As vacancies arise new Trustees are appointed.

Trustee induc'on and training

Newly appointed trustees receive comprehensive induc�on including training on their du�es and responsibili�es under company and charity law and also an induc�on into the ac�vi�es, opera�onal plans and financial performance of the charity.

Organisa'on

The Board of Trustees is ul�mately responsible for the management of the Neuromuscular Centre. The Board will meet quarterly. A Chief Execu�ve, with delegated authority, is appointed by and accountable to the trustees for managing the day­to­day opera�ons of the NMC and the delivery of opera�onal plans.

The remunera�on arrangements for all staff are reviewed annually by the Chair of Trustees and Chief Execu�ve having benchmarked pay levels in the relevant employment roles and sectors and mindful of changes to the UK cost of living indices. The Trustee Board approve the overall remunera�on seBlement as part of the annual budget seCng.

Auditor

In accordance with the company's ar�cles, a resolu�on proposing that Mitchell Charlesworth (Audit) Limited be reappointed as auditor of the company will be put at a General Mee�ng.

Disclosure of informa'on to auditor

Each of the trustees has confirmed that there is no informa�on of which they are aware which is relevant to the audit, but of which the auditor is unaware. They have further confirmed that they have taken appropriate steps to iden�fy such relevant informa�on and to establish that the auditor is aware of such informa�on.

NEUROMUSCULAR CENTRE COMPANY LIMITED BY GUARANTEE TRUSTEES' REPORT (CONTINUED)(INCLUDING DIRECTORS' REPORT)

FOR THE YEAR ENDED 31 MARCH 2025

Small company provisions

This report has been prepared in accordance with the special provisions rela�ng to small companies within Part 15 of the Companies Act 2006.

On behalf of the board of trustees

W Duckworth (Chair)

Trustee Dated: 29 January 2026

NEUROMUSCULAR CENTRE COMPANY LIMITED BY GUARANTEE STATEMENT OF TRUSTEES' RESPONSIBILITIES

FOR THE YEAR ENDED 31 MARCH 2025

The trustees, who are also the directors of NeuroMuscular Centre for the purpose of company law, are responsible for preparing the Trustees' Report and the accounts in accordance with applicable law and United Kingdom Accoun ng Standards (United Kingdom Generally Accepted Accoun ng Prac ce).

Company Law requires the trustees to prepare accounts for each financial year which give a true and fair view of the state of affairs of the charity and of the incoming resources and applica on of resources, including the income and expenditure, of the charitable company for that year.

In preparing these accounts, the trustees are required to:

­ select suitable accoun ng policies and then apply them consistently;

­ observe the methods and principles in the Chari es SORP;

­ make judgements and es mates that are reasonable and prudent;

­ state whether applicable UK Accoun ng Standards have been followed, subject to any material departures disclosed and explained in the accounts; and

­ prepare the accounts on the going concern basis unless it is inappropriate to presume that the charity will con nue in opera on.

The trustees are responsible for keeping adequate accoun ng records that disclose with reasonable accuracy at any me the financial posi on of the charity and enable them to ensure that the accounts comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charity and hence for taking reasonable steps for the preven on and detec on of fraud and other irregulari es.

NEUROMUSCULAR CENTRE COMPANY LIMITED BY GUARANTEE INDEPENDENT AUDITOR'S REPORT

TO THE MEMBERS OF NEUROMUSCULAR CENTRE

Opinion

We have audited the financial statements of NeuroMuscular Centre (the ‘charity’) for the year ended 31 March 2025 which comprise the statement of financial ac#vi#es, the balance sheet, the statement of cash flows and notes to the financial statements, including significant accoun#ng policies. The financial repor#ng framework that has been applied in their prepara#on is applicable law and United Kingdom Accoun#ng Standards, including Financial Repor#ng Standard 102 The Financial Repor�ng Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accoun#ng Prac#ce).

Basis for opinion

We conducted our audit in accordance with Interna#onal Standards on Audi#ng (UK) (ISAs (UK)) and applicable law. Our responsibili#es under those standards are further described in the Auditor's responsibili�es for the audit of the financial statements sec#on of our report. We are independent of the charity in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibili#es in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions rela"ng to going concern

In audi#ng the financial statements, we have concluded that the trustees' use of the going concern basis of accoun#ng in the prepara#on of the financial statements is appropriate.

Based on the work we have performed, we have not iden#fied any material uncertain#es rela#ng to events or condi#ons that, individually or collec#vely, may cast significant doubt on the charity’s ability to con#nue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibili#es and the responsibili#es of the trustees with respect to going concern are described in the relevant sec#ons of this report.

Other informa"on

The other informa#on comprises the informa#on included in the annual report other than the financial statements and our auditor's report thereon. The trustees are responsible for the other informa#on contained within the annual report. Our opinion on the financial statements does not cover the other informa#on and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other informa#on and, in doing so, consider whether the other informa#on is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we iden#fy such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other informa#on, we are required to report that fact.

We have nothing to report in this regard.

Opinions on other ma'ers prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of our audit:

NEUROMUSCULAR CENTRE COMPANY LIMITED BY GUARANTEE INDEPENDENT AUDITOR'S REPORT (CONTINUED)

TO THE MEMBERS OF NEUROMUSCULAR CENTRE

Ma�ers on which we are required to report by excep+on

In the light of the knowledge and understanding of the charity and its environment obtained in the course of the audit, we have not iden�fied material misstatements in the directors' report included within the trustees' report.

We have nothing to report in respect of the following ma�ers in rela�on to which the Companies Act 2006 requires us to report to you if, in our opinion:

Responsibili+es of trustees

As explained more fully in the statement of trustees' responsibili�es, the trustees, who are also the directors of the charity for the purpose of company law, are responsible for the prepara�on of the financial statements and for being sa�sfied that they give a true and fair view, and for such internal control as the trustees determine is necessary to enable the prepara�on of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the trustees are responsible for assessing the charity’s ability to con�nue as a going concern, disclosing, as applicable, ma�ers related to going concern and using the going concern basis of accoun�ng unless the trustees either intend to liquidate the charitable company or to cease opera�ons, or have no realis�c alterna�ve but to do so.

Auditor's responsibili+es for the audit of the financial statements

Our objec�ves are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which our procedures are capable of detec�ng irregulari�es, including fraud, is detailed below.

Our approach to iden�fying and assessing the risks of material misstatement in respect of irregulari�es, including fraud and non­compliance with laws and regula�ons, was as follows:

NEUROMUSCULAR CENTRE COMPANY LIMITED BY GUARANTEE INDEPENDENT AUDITOR'S REPORT (CONTINUED)

TO THE MEMBERS OF NEUROMUSCULAR CENTRE

We assessed the suscep�bility of the company’s financial statements to material misstatement, including obtaining an understanding of how fraud might occur, by:

To address the risk of fraud through management bias and override of controls, we:

In response to the risk of irregulari�es and non­compliance with laws and regula�ons, we designed procedures which included, but were not limited to:

There are inherent limita�ons in our audit procedures described above. The more removed that laws and regula�ons are from financial transac�ons, the less likely it is that we would become aware of non­compliance. Audi�ng standards also limit the audit procedures required to iden�fy non­compliance with laws and regula�ons to enquiry of the directors and other management and the inspec�on of regulatory and legal correspondence, if any.

Material misstatements that arise due to fraud can be harder to detect than those that arise from error as they may involve deliberate concealment or collusion.

A further descrip�on of our responsibili�es is available on the Financial Repor�ng Council’s website at: h+ps:// www.frc.org.uk/auditorsresponsibili�es. This descrip�on forms part of our auditor's report.

Other ma�ers

This report is made solely to the charitable company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the charitable company's members those ma+ers we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permi+ed by law, we do not accept or assume responsibility to anyone other than the charitable company and the charitable company’s members as a body, for our audit work, for this report, or for the opinions we have formed.

Mr Tony Stanley ACA (Senior Statutory Auditor) for and on behalf of Mitchell Charlesworth (Audit) Limited 29 January 2026

Accountants

Statutory Auditor

Suites C,D,E, & F 14th Floor The Plaza 100 Old Hall Street Liverpool L3 9QJ

NEUROMUSCULAR CENTRE COMPANY LIMITED BY GUARANTEE STATEMENT OF FINANCIAL ACTIVITIES

FOR THE YEAR ENDED 31 MARCH 2025

Current fnancial year Current fnancial year Current fnancial year
Unrestricted Restricted Endowment Total As restated
funds funds funds Total
2025 2025 2025 2025 2024
Notes £ £ £ £ £
Income from:
Dona�ons and legacies 3 292,427 39,263 100,000 431,690 394,037
Charitable ac� vi� es 5 894,750 ­ ­ 894,750 715,156
Fundraising events 4 32,286 ­ ­ 32,286 72,697
Investments 6 11,368 ­ ­ 11,368 8,426
Other income 7 474 25,000 (25,000) 474 315
Total income and endowments 1,231,305 64,263 75,000 1,370,568 1,190,631
Expenditure on:
Raising funds 8 106,230 ­ ­ 106,230 155,671
Charitable ac� vi� es 9 1,101,393 68,757 ­ 1,170,150 998,942
Total expenditure 1,207,623 68,757 ­ 1,276,380 1,154,613
Net movement in funds 23,682 (4,494) 75,000 94,188 36,018
Reconcilia4on of funds
Fund balances at 1 April 2024 1,307,962 11,837 ­ 1,319,799 1,283,781
Fund balances at 31 March 2025 1,331,644 7,343 75,000 1,413,987 1,319,799

The statement of financial ac�vi�es includes all gains and losses recognised in the year.

All income and expenditure derive from con�nuing ac�vi�es.

The movement in funds detailed above complies with the requirements for a statement of changes in equity under FRS102.

NEUROMUSCULAR CENTRE COMPANY LIMITED BY GUARANTEE STATEMENT OF FINANCIAL ACTIVITIES (CONTINUED)

FOR THE YEAR ENDED 31 MARCH 2025

Prior fnancial year year
As restated As restated
Unrestricted Restricted Total
funds funds
2024 2024 2024
Notes £ £ £
Income from:
Dona�ons and legacies 3 358,420 35,617 394,037
Charitable ac� vi� es 5 715,156 ­ 715,156
Fundraising events 4 72,697 ­ 72,697
Investments 6 8,426 ­ 8,426
Other income 7 315 ­ 315
Total income and endowments 1,155,014 35,617 1,190,631
Expenditure on:
Raising funds 8 155,671 ­ 155,671
Charitable ac� vi� es 9 964,012 34,930 998,942
Total expenditure 1,119,683 34,930 1,154,613
Net movement in funds 35,331 687 36,018
Reconcilia4on of funds
Fund balances at 1 April 2023 1,272,631 11,150 1,283,781
Fund balances at 31 March 2024 1,307,962 11,837 1,319,799

The statement of financial ac�vi�es includes all gains and losses recognised in the year.

All income and expenditure derive from con�nuing ac�vi�es.

The movement in funds detailed above complies with the requirements for a statement of changes in equity under FRS102.

NEUROMUSCULAR CENTRE COMPANY LIMITED BY GUARANTEE BALANCE SHEET

AS AT 31 MARCH 2025

2025 2024
as restated
Notes £ £ £ £
Fixed assets
Tangible assets 14 743,796 712,408
Investments 15 9 9
743,805 712,417
Current assets
Debtors 18 153,669 149,349
Cash at bank and in hand 665,152 587,222
818,821 736,571
Creditors: amounts falling due within one year 19 (148,639) (129,189)
Net current assets 670,182 607,382
Total assets less current liabili2es 1,413,987 1,319,799
The funds of the charity
Endowment funds 22 75,000 ­
Restricted income funds 23 7,343 11,837
Unrestricted funds 24 1,331,644 1,307,962
1,413,987 1,319,799

The financial statements were approved by the trustees on 29 January 2026

W Duckworth (Chair from 2 May 2024)

Trustee

Company registra1on number 2806607 (England and Wales)

NEUROMUSCULAR CENTRE COMPANY LIMITED BY GUARANTEE STATEMENT OF CASH FLOWS

FOR THE YEAR ENDED 31 MARCH 2025

2025 2024
Notes £ £ £ £
Cash fows from opera'ng ac'vi'es
Net cash provided by opera�ng ac�vi�es 30 127,403 57,355
Cash fows from inves'ng ac'vi'es
Purchase of tangible fxed assets (60,842) (8,380)
Interest received 11,368 8,426
Net cash (used in)/generated from inves'ng
ac'vi'es (49,474) 46
Net increase in cash and cash equivalents 77,929 57,401
Cash and cash equivalents at beginning of year 587,222 529,824
Cash and cash equivalents at end of year 665,152 587,222

NEUROMUSCULAR CENTRE COMPANY LIMITED BY GUARANTEE NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2025

1 Accoun�ng policies

Charity informa�on

The NeuroMuscular Centre is a private company limited by guarantee incorporated in England and Wales and a charity registered with the Charity Commission for England and Wales. The registered office is Woodford Lane West, Winsford, Cheshire, CW7 4EH.

1.1 Accoun�ng conven�on

The financial statements have been prepared in accordance with the charity's Memorandum and Ar'cles of Associa'on, the Companies Act 2006, FRS 102 “The Financial Repor'ng Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the Chari'es SORP "Accoun'ng and Repor'ng by Chari'es: Statement of Recommended Prac'ce applicable to chari'es preparing their accounts in accordance with the Financial Repor'ng Standard applicable in the UK and Republic of Ireland (FRS 102)" (effec've 1 January 2019). The charity is a Public Benefit En'ty as defined by FRS 102.

The accounts are prepared in sterling, which is the func'onal currency of the charity. Monetary amounts in these financial statements are rounded to the nearest £.

The accounts have been prepared on the historical cost conven'on. The principal accoun'ng policies adopted are set out below.

The financial statements do not incorporate the results, assets and liabili'es of the charity's wholly owned subsidiary, NMC Trading Limited. Consolidated accounts have not been prepared as these would not be materially different from the single en'ty financial statements as presented. The subsidiary ceased to trade on 1 April 2012 and has remained dormant throughout the period.

1.2 Going concern

At the 'me of approving the accounts the Trustees have a reasonable expecta'on that the charity has adequate resources to con'nue in opera'onal existence for the foreseeable future. Thus, the Trustees con'nue to adopt the ‘going concern’ basis of accoun'ng in preparing the accounts.

1.3 Charitable funds

Funds held by the charity are:

Unrestricted general funds ­ these are funds which can be used in accordance with the charitable objects at the discre'on of the trustees, with due regard to the reserves policy as described in the Trustees' Report.

Designated funds ­ these are funds set aside by the trustees out of unrestricted general funds for specific future purposes.

Restricted funds are funds which are to be used in accordance with specific restric'ons imposed by donors or which have been raised by the charity for par'cular purposes. The aim and use of each restricted fund is set out in the notes to the financial statements.

Endowment funds are subject to specific condi'ons by donors that the capital must be maintained by the charity.

NEUROMUSCULAR CENTRE COMPANY LIMITED BY GUARANTEE NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 MARCH 2025

1 Accoun�ng policies

(Con�nued)

1.4 Income

All income is included in the Statement of Financial Ac�vi�es when the charity is legally en�tled to the income and the amount can be quan�fied with reasonable accuracy.

Income from dona�ons and grants, including capital grants, is included in income when these are receivable, except as follows:

Legacies are recognised on receipt or otherwise if the charity has been no�fied of an impending distribu�on, the amount is known, and receipt is expected. If the amount is not known, the legacy is treated as a con�ngent asset.

Income is deferred only when the charity has to fulfil condi�ons before becoming en�tled to it or where the donor has specified that the income is to be expended in a future period.

When donors specify that dona�ons and grants, including capital grants, are for par�cular restricted purposes, which do not amount to precondi�ons regarding en�tlement, this income is included as restricted funds when receivable.

Voluntary income includes discre�onary grants for projects, goods and services where no service agreement or contract exists.

Other grants, which have par�cular service requirements and which are provided in accordance with a contract or service level agreement are included in the Statement of Financial Ac�vi�es under the heading Charitable Ac�vi�es.

Interest is included when receivable by the charity.

1.5 Expenditure

Expenditure reflects all amounts paid and accrued during the year. Expenditure includes any VAT which cannot be fully recovered, and is reported as part of the expenditure to which it relates. All costs are allocated between the expenditure categories of the Statement of Financial Ac�vi�es (SOFA) on a basis designed to reflect the use of the resource.

Raising funds

These represent costs incurred in seeking voluntary contribu�ons and do not include the costs of dissemina�ng informa�on in support of the charitable ac�vi�es.

Charitable expenditure

Charitable expenditure comprises those costs incurred by the charity in the delivery of its ac�vi�es and services for its beneficiaries. It includes both costs that can be allocated directly to such ac�vi�es and those costs of an indirect nature necessary to support them. Support costs are allocated across the ac�vi�es on the basis of expenditure incurred for each of the ac�vi�es.

Governance costs

These represent costs associated with mee�ng the cons�tu�onal and statutory requirements of the charity and include the audit fees and costs linked to the strategic management of the charity.

NEUROMUSCULAR CENTRE COMPANY LIMITED BY GUARANTEE NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 MARCH 2025

1 Accoun�ng policies

(Con�nued)

1.6 Tangible fixed assets

Tangible fixed assets are ini�ally measured at cost and subsequently measured at cost or valua�on, net of deprecia�on and any impairment losses.

Individual fixed assets cos�ng £1,000 or more are capitalised at cost, including any expenses of acquisi�on.

Deprecia�on is provided at rates calculated to write off the cost less es�mated residual value of each asset over its expected useful life, as follows:

Short leasehold property Straight line basis over the life of the lease Fixtures, fi'ngs & equipment Straight line over 4 ­ 5 years

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is recognised in the statement of financial ac�vi�es.

1.7 Fixed asset investments

Fixed asset investments are stated at cost less provision for diminu�on in value.

1.8 Impairment of fixed assets

At each repor�ng end date, the charity reviews the carrying amounts of its tangible assets to determine whether there is any indica�on that those assets have suffered an impairment loss. If any such indica�on exists, the recoverable amount of the asset is es�mated in order to determine the extent of the impairment loss (if any).

1.9 Cash and cash equivalents

Cash and cash equivalents include cash in hand, deposits held at call with banks, other short­term liquid investments with original maturi�es of three months or less, and bank overdra1s.

1.10 Financial instruments

The charity has elected to apply the provisions of Sec�on 11 ‘Basic Financial Instruments’ and Sec�on 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the charity's balance sheet when the charity becomes party to the contractual provisions of the instrument.

Financial assets and liabili�es are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an inten�on to se9le on a net basis or to realise the asset and se9le the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are ini�ally measured at transac�on price including transac�on costs and are subsequently carried at amor�sed cost using the effec�ve interest method unless the arrangement cons�tutes a financing transac�on, where the transac�on is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amor�sed.

NEUROMUSCULAR CENTRE COMPANY LIMITED BY GUARANTEE NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 MARCH 2025

1 Accoun�ng policies

(Con�nued)

Basic financial liabili�es

Basic financial liabili�es, including creditors and bank loans are ini�ally recognised at transac�on price unless the arrangement cons�tutes a financing transac�on, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabili�es classified as payable within one year are not amor�sed.

Debt instruments are subsequently carried at amor�sed cost, using the effec�ve interest rate method.

Trade creditors are obliga�ons to pay for goods or services that have been acquired in the ordinary course of opera�ons from suppliers. Amounts payable are classified as current liabili�es if payment is due within one year or less. If not, they are presented as non­current liabili�es. Trade creditors are recognised ini�ally at transac�on price and subsequently measured at amor�sed cost using the effec�ve interest method.

Derecogni�on of financial liabili�es

Financial liabili�es are derecognised when the charity’s contractual obliga�ons expire or are discharged or cancelled.

1.11 Employee benefits

The cost of any unused holiday en�tlement is recognised in the period in which the employee’s services are received, if material.

Termina�on benefits are recognised immediately as an expense when the charity is demonstrably commi'ed to terminate the employment of an employee or to provide termina�on benefits.

1.12

The charity offers defined contribu�on pension arrangements to an employers’ portable scheme. Contribu�ons are charged in the financial statements as incurred.

1.13 Taxa�on

The charity benefits from various exemp�ons from taxa�on afforded by tax legisla�on and is not liable to corpora�on tax on income or gains falling within those exemp�ons. Recovery is made of tax deducted from qualifying income and from receipts under Gi+ Aid.

The charity is also able to par�ally recover Value Added Tax. Expenditure that is not recoverable by the charity is recorded in the accounts inclusive of VAT.

2 Cri�cal accoun�ng es�mates and judgements

In the applica�on of the charity’s accoun�ng policies, the trustees are required to make judgements, es�mates and assump�ons about the carrying amount of assets and liabili�es that are not readily apparent from other sources. The es�mates and associated assump�ons are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these es�mates.

The es�mates and underlying assump�ons are reviewed on an ongoing basis. Revisions to accoun�ng es�mates are recognised in the period in which the es�mate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

There are no cri�cal accoun�ng es�mates or judgments included in these accounts.

tho 0￿0

NEUROMUSCULAR CENTRE COMPANY LIMITED BY GUARANTEE NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 MARCH 2025

4 Income from other trading ac%vi%es

Unrestricted Unrestricted
funds funds
2025 2024
£ £
Fundraising events 32,286 72,697
Unrestricted Unrestricted Unrestricted Unrestricted
funds funds funds funds
Physiotherapy Suppor%ng Total Total
employment 2025 2024
£ £ £ £
Income within charitable ac�vi�es 799,882 94,868 894,750 715,156

For the year ended 31 March 2024

Physiotherapy Physiotherapy Suppor%ng Suppor%ng Total
employment
£ £ £
Income within charitable ac�vi�es 613,533 101,623 715,156
Analysis by fund
Unrestricted funds 613,533 101,623 715,156

6 Income from investments

Unrestricted Unrestricted
funds funds
2025 2024
£ £
Interest receivable 11,368 8,426

NEUROMUSCULAR CENTRE COMPANY LIMITED BY GUARANTEE NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 MARCH 2025

7 Other income

Unrestricted Restricted Endowment Total Unrestricted
funds funds funds funds
2025 2025 2025 2025 2024
£ £ £ £ £
Edward Gostling Fund ­ 25,000 (25,000) ­ ­
Other income 474 ­ ­ 474 315

During the year £25,000 (2024: nil) was released as income from the capital endowment fund in line with the terms of the fund.

Other income relates to a Feed­in Tariff (FIT) payment received from the charity's energy provider.

8 Raising funds

Unrestricted Unrestricted
funds funds
2025 2024
£ £
Costs of genera/ng dona/ons and legacies and events
Promo/on 41,563 59,543
Staf costs 64,369 86,244
Share of support costs (see note 10) 298 9,884
106,230 155,671

NEUROMUSCULAR CENTRE COMPANY LIMITED BY GUARANTEE NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 MARCH 2025

9 Charitable ac!vi!es

**Physiotherapy ** **Physiotherapy ** Advocacy and Advocacy and
Suppor!ng
Suppor!ng		 Training Total Total
care support employment 2025 2024
£ £ £ £ £ £
Staf costs 326,266 240,401 119,112 26,266 712,045 356,617
Share of support costs (see
note 10) 27,049 336,034 72,672 5,482 441,237 627,837
Share of governance costs
(see note 10) 4,217 4,217 4,217 4,217 16,868 14,488
357,532 580,652 196,001 35,965 1,170,150 998,942
Analysis by fund
Unrestricted funds 288,775 580,652 196,001 35,965 1,101,393
Restricted funds 68,757 ­ ­ ­ 68,757
357,532 580,652 196,001 35,965 1,170,150

For the year ended 31 March 2024

**Physiotherapy ** **Physiotherapy ** Advocacy and Advocacy and
Suppor!ng
Suppor!ng		 Training Total
care support employment
£ £ £ £ £
Staf costs 195,690 80,392 65,374 15,161 356,617
Share of support costs (see note 10) 55,185 418,863 111,622 42,167 627,837
Share of governance costs (see note 10) 3,622 3,622 3,622 3,622 14,488
254,497 502,877 180,618 60,950 998,942
Analysis by fund
Unrestricted funds 254,497 467,947 180,618 60,950 964,012
Restricted funds ­ 34,930 ­ ­ 34,930
254,497 502,877 180,618 60,950 998,942

NEUROMUSCULAR CENTRE COMPANY LIMITED BY GUARANTEE NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 MARCH 2025

10 Support costs allocated to ac$vi$es

Support costs allocated to ac$vi$es
As restated
2025 2024
£ £
Staf costs 55,911 288,507
Deprecia�on 29,453 23,513
U�li�es and communica�ons 17,487 23,652
Travel 24,068 23,900
Prin�ng 79,498 82,652
Maintenance 86,034 47,742
Insurance and general expenses 116,121 100,552
Non recoverable VAT 32,963 47,203
Governance costs 16,868 14,488
458,403 652,209
Analysed between:
Fundraising 298 9,884
Physiotherapy 31,266 58,807
Advocacy and Care Support 340,251 422,485
Suppor�ng Employment 76,889 115,244
Training 9,699 45,789
458,403 652,209

Support costs are allocated on the basis of �me spent/usage. Governance costs are split equally between ac�vi�es.

11 Auditor's remunera$on

The analysis of auditor's remunera�on is as follows:

The analysis of auditor's remunera�on is as follows:
2025 2024
£ £
Fees payable to the company's auditor for the audit of the company's annual
accounts 4,800 4,250
All other non­audit services 2,700 4,220

12 Trustees

None of the trustees (or any persons connected with them) received any remunera�on during the year (2024: £nil) and no trustees were reimbursed expenses (2024: none).

NEUROMUSCULAR CENTRE COMPANY LIMITED BY GUARANTEE NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 MARCH 2025

13 Employees

Number of employees

The average monthly number of employees during the year was:

The average monthly number of employees during the year was:
2025 2024
Number Number
Charitable ac�vi�es 28 26
Fundraising 2 3
Administra�on 1 1
31 30
Employment costs 2025 2024
£ £
Wages and salaries 710,233 636,781
Social security costs 57,264 38,185
Other pension costs 64,828 56,402
832,325 731,368

There were no employees whose annual remunera�on was £60,000 or more (2024: none).

14 Tangible fixed assets

Tangible fxed assets
Short leasehold
Fixtures, f4ngs		 Total
property & equipment
£ £ £
Cost
At 1 April 2024 1,100,225 285,889 1,386,114
Addi�ons 37,548 23,294 60,842
At 31 March 2025 1,137,773 309,183 1,446,956
Deprecia7on
At 1 April 2024 408,643 265,063 673,706
Deprecia�on charged in the year 14,766 14,688 29,454
At 31 March 2025 423,409 279,751 703,160
Carrying amount
At 31 March 2025 714,364 29,432 743,796
At 31 March 2024 691,582 20,826 712,408

All tangible assets are used in func�ons of the charity and are shown at wri1en down cost. All material assets are used for direct charitable ac�vi�es. The leasehold land and buildings are subject to a lease that has recently been renewed and will expire in August 2077.

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

NEUROMUSCULAR CENTRE COMPANY LIMITED BY GUARANTEE

FOR THE YEAR ENDED 31 MARCH 2025

15 Fixed asset investments

Other investments

Cost or valua(on
At 1 April 2024 & 31 March 2025 9
Carrying amount
At 31 March 2025 9
At 31 March 2024 9
2025 2024
Other investments comprise: Notes £ £
Investments in subsidiaries 16 9 9
Subsidiaries
Details of the charity's subsidiary at 31 March 2025 are as follows:
Name of undertaking and country of Nature of business Class of % Held
incorpora(on or residency shareholding Direct Indirect
NMC Trading Limited England and Dormant Ordinary
Wales 100.00 ­

16 Subsidiaries

The aggregate capital and reserves and the result for the year of subsidiaries excluded from consolida/on was as follows:

Name of undertaking Proft/(Loss) Capital and
Reserves
£ £
NMC Trading Limited ­ 9

NEUROMUSCULAR CENTRE COMPANY LIMITED BY GUARANTEE NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 MARCH 2025

17 Financial instruments 2025 2024
£ £
Carrying amount of fnancial assets
Debt instruments measured at cost 787,264 708,131
Equity instruments measured at cost 9 9
787,273 708,140
Carrying amount of fnancial liabili/es
Measured at cost 23,902 13,315
18 Debtors
2025 2024
Amounts falling due within one year: £ £
Trade debtors 122,112 80,909
Other debtors 4,226 45,693
Prepayments and accrued income 27,331 22,747
153,669 149,349
19 Creditors: amounts falling due within one year
As restated
2025 2024
Notes £ £
Other taxa%on and social security 94,178 58,411
Deferred income 20 30,559 57,463
Trade creditors 16,608 6,006
Amounts due to subsidiary undertakings 9 9
Accruals 7,285 7,300
148,639 129,189

NEUROMUSCULAR CENTRE COMPANY LIMITED BY GUARANTEE NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 MARCH 2025

20 Deferred income
2025 2024
£ £
Other deferred income 30,559 57,463
30,559 57,463
Deferred income is included in the fnancial statements as follows:
2025 2024
£ £
Total deferred income at 1 April 2024 57,463 117,815
Amounts received in year 30,559 57,463
Amounts credited to statement of fnancial ac&vi&es (57,463) (117,815)
30,559 57,463
21 Re&rement beneft schemes
2025 2024
Defned contribu&on schemes £ £
Charge to proft or loss in respect of defned contribu&on schemes 64,828 56,402

The charity operates a defined contribu&on pension scheme for all qualifying employees. The assets of the scheme are held separately from those of the charity in an independently administered fund.

22 Endowment funds

Endowment funds represent assets which must be held permanently by the charity. Income arising on the endowment funds can be used in accordance with the objects of the charity and is included as unrestricted income. Any capital gains or losses arising on the assets form part of the fund.

At 1 April 2024 Income Expenditure Transfers At 31 March
2025
£ £ £ £ £
Expendable endowments
The Edward Gostling Fund ­ 75,000 ­ ­ 75,000

The Edward Gostling Fund has agreed to provide funding of £100,000 to Neuromuscular Centre for theestablishment of an endowment fund, the capital of which Neuromuscular Centre can use to invest and generate income to be used to further its charitable ac&vi&es over the next four years. During the year £25,000 has been converted into restricted income, this is shown on the 'other income' line of the Statement of Financial Ac&vi&es.

ol o mNo i ￿ Ln Iri N Ln J ZS C

NEUROMUSCULAR CENTRE COMPANY LIMITED BY GUARANTEE NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 MARCH 2025

24 Unrestricted funds

The unrestricted funds of the charity comprise the unexpended balances of dona�ons and grants which are not subject to specific condi�ons by donors and grantors as to how they may be used. These include designated funds which have been set aside out of unrestricted funds by the trustees for specific purposes.

At 1 April 2024 At 1 April 2024 Income Expenditure Expenditure Transfers At 31 March At 31 March
2025
£ £ £ £ £
Car park works 40,000 ­ (37,548) (2,452) ­
General funds 1,267,962 1,231,305 (1,170,075) 2,452 1,331,644
1,307,962 1,231,305 (1,207,623) ­ 1,331,644
Previous year: At 1 April 2023 Income Expenditure Transfers At 31 March
2024
£ £ £ £ £
Car park works ­ ­ ­ 40,000 40,000
General funds 1,272,631 1,155,014 (1,119,683) (40,000) 1,267,962
1,272,631 1,155,014 1,119,683 ­ 1,307,962

£40,000 had been designated in the prior year to fund the costs of resurfacing the Centre's car park which was completed in 2024/25 for £37,548, the excess was released back to general unrestricted funds.

oj ¢Tr OJ ¢Tr In

NEUROMUSCULAR CENTRE COMPANY LIMITED BY GUARANTEE NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 MARCH 2025

26 Capital commitments

Amounts contracted for but not provided in the financial statements:

Amounts contracted for but not provided in the fnancial statements:
2025 2024
£ £
Acquisi�on of property, plant and equipment 78,348 40,000

The above capital commitment for 2025 relates to work carried out at the Centre.

The prior year capital commitment related to work carried out at the Centre car park. This amount had been set aside at the year end as a designated fund, see note 23.

27 Opera*ng lease commitments

At the repor�ng end date the charity had outstanding commitments for future minimum lease payments under non­ cancellable opera�ng leases, which fall due as follows:

2025 2024
£ £
Within one year 1,320 598
Between two and fve years 1,650 ­
2,970 598

28 Related party transac*ons

Remunera*on of key management personnel

The remunera�on of key management personnel, is as follows.

2025 2024
£ £
Aggregate remunera�on 68,485 61,969

As at 31 March 2025, there is a creditor balance owing to the wholly owned subsidiary NMC Trading Limited of £9 (2024: £9).

There were no other related party transac�ons.

No guarantees have been given or received.

NEUROMUSCULAR CENTRE COMPANY LIMITED BY GUARANTEE NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 MARCH 2025

29 Company limited by guarantee

The Neuromuscular Centre is incorporated under the Companies Act as a company limited by guarantee. The liability of the members is limited to £1.

30 Cash generated from opera-ons 2025 2024
£ £
Net income for the year (as per the statement of fnancial ac�vi�es) 94,188 36,018
Adjustments for:
Investment income recognised in statement of fnancial ac�vi�es (11,368) (8,426)
Deprecia�on of tangible fxed assets 29,453 23,513
Movements in working capital:
(Increase)/decrease in debtors (4,320) 29,928
Increase in creditors 46,354 36,674
(Decrease) in deferred income (26,904) (60,352)
Net cash provided by opera-ng ac-vi-es 127,403 57,355

NEUROMUSCULAR CENTRE COMPANY LIMITED BY GUARANTEE NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 MARCH 2025

31 Prior period adjustment

Changes to the balance sheet

Changes to the balance sheet
At 31 March 2024
As previously
Adjustment		 As restated
reported
£ £ £
Creditors due within one year
Taxa�on (11,208) (47,203) (58,411)
Capital funds
Income funds
Restricted funds 11,837 ­ 11,837
Unrestricted funds 1,355,165 (47,203) 1,307,962
Total equity 1,367,002 (47,203) 1,319,799
Changes to the proft and loss account
Period ended 31 March 2024
As previously
Adjustment		 As restated
reported
£ £ £
Charitable ac�vi�es 951,739 47,203 998,942
Net movement in funds 83,221 (47,203) 36,018

Following the year end, the en�ty performed a detailed review of its VAT recovery posi�on. This review iden�fied that in the current and prior periods, input VAT had been over­claimed due to business / non­business and par�al exemp�on adjustments not being fully applied.

As a result, the element of the iden�fied liability that relates to the period prior to 31 March 2024 has been included as a prior period error in accordance with FRS 102 Sec�on 10, which has been reflected in the compara�ve figures.